Pages that link to "Q47897731"
Jump to navigation
Jump to search
The following pages link to Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. (Q47897731):
Displaying 50 items.
- 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells (Q24321415) (← links)
- Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology (Q26751386) (← links)
- MicroRNAs and Their Therapeutic Potential for Human Diseases: MiR-133a and Bronchial Smooth Muscle Hyperresponsiveness in Asthma (Q28295928) (← links)
- TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis (Q30587902) (← links)
- Sputum proteomics in inflammatory and suppurative respiratory diseases (Q33345110) (← links)
- IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis (Q33481984) (← links)
- A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma (Q33523148) (← links)
- Neutralisation of Interleukin-13 in Mice Prevents Airway Pathology Caused by Chronic Exposure to House Dust Mite (Q33722148) (← links)
- Airway wall expression of OX40/OX40L and interleukin-4 in asthma (Q33776845) (← links)
- Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. (Q34331327) (← links)
- Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation (Q34580221) (← links)
- Sputum IgE and cytokines in asthma: relationship with sputum cellular profile (Q34650356) (← links)
- Interleukin-13: prospects for new treatments (Q35010562) (← links)
- IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling (Q35072420) (← links)
- OX40/OX40 ligand interactions in T-cell regulation and asthma (Q35750177) (← links)
- Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice (Q36004549) (← links)
- Differences in radiological/HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness. (Q36148646) (← links)
- Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease (Q36237040) (← links)
- Mast cells in airway diseases and interstitial lung disease (Q36260500) (← links)
- The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells (Q36364561) (← links)
- Immunogenetic programs for viral induction of mucous cell metaplasia (Q36423688) (← links)
- Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation (Q36494927) (← links)
- Diagnosis and treatment of chronic cough in China: an insight into the status quo. (Q36544391) (← links)
- Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients (Q36765753) (← links)
- Interleukin-13 signaling and its role in asthma (Q36834591) (← links)
- Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma (Q37239764) (← links)
- Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. (Q37337400) (← links)
- Cough due to asthma and nonasthmatic eosinophilic bronchitis (Q37577528) (← links)
- Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis (Q37711393) (← links)
- Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma (Q37711405) (← links)
- Increased sputum and bronchial biopsy IL-13 expression in severe asthma (Q37711413) (← links)
- Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. (Q37711416) (← links)
- Use of biologicals as immunotherapy in asthma and related diseases (Q37754792) (← links)
- Eosinophilic bronchitis, eosinophilia associated genetic variants, and notch signaling in asthma (Q37769118) (← links)
- RhoA, a Possible Target for Treatment of Airway Hyperresponsiveness in Bronchial Asthma (Q37800325) (← links)
- Asthma: a simple concept but in reality a complex disease (Q37880256) (← links)
- Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches? (Q37909700) (← links)
- Monoclonal antibodies for the treatment of asthma (Q37938210) (← links)
- Lung damage and airway remodelling in severe asthma. (Q37970841) (← links)
- EAACI consensus statement for investigation of work-related asthma in non-specialized centres. (Q37976879) (← links)
- An update on emerging drugs for asthma (Q37980187) (← links)
- Innate and adaptive immune responses in asthma (Q38007827) (← links)
- Phenotyping airways disease: an A to E approach. (Q38062584) (← links)
- An update on biologic-based therapy in asthma (Q38159806) (← links)
- Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies. (Q38285983) (← links)
- Association of interleukin-13 C-1112T and G+2044A polymorphisms with asthma: a meta-analysis (Q38422217) (← links)
- Airway epithelium interactions with aeroallergens: role of secreted cytokines and chemokines in innate immunity (Q38425485) (← links)
- Anti-IL-4/-13 based therapy in asthma (Q38506152) (← links)
- Lebrikizumab in the treatment of asthma (Q38830570) (← links)
- Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update (Q38908862) (← links)